MRI measures of cerebral blood flow and white matter hyperintensities differentiated NDAN from AD+MCI, highlighting vascular contributions to cognitive resilience, and CBF differentiated AD+MCI from Controls.
Global and occipital PSMD may help identify AD participants with concomitant cerebral amyloid angiopathy (CAA) and DTI‐ALPS indices were associated with preserved language function and memory, and no PSMD metric was associated with any clinical measure.
Debina Laishram, G. Du, Sangam Kanekar et al.· Annals of Clinical and Trans...· 0 citations
Objective Alzheimer’s disease (AD) is characterized by amyloid deposition, brain hypometabolism, gray matter atrophy and cognitive decline, yet their causal interactions are poorly defined. This multimodal PET/MRI study explored regional gray matter volume (GMV) loss and glucose hypometabolism in AD patients, and clari...
Shi-Qi Zhao, Jian-Wen Chen, Pei-Xue Li et al.· Frontiers in Neurology· 0 citations
White matter SC is affected in AD, particularly in medial temporal lobe regions that are known to be affected early in the disease, particularly in medial temporal lobe regions that are known to be affected early in the disease.
Sarah E. Cote, M. Ruitenberg, J. N. van der Geest et al.· Neuroimage: Reports· 0 citations
OBJECTIVE
Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and...
Daniele Urso, Thomas Giannelli, B. Tafuri et al.· Annals of Neurology· 0 citations
Automated MRI volumetry may support the quantitative assessment of neurodegeneration in clinically defined AD and MCI, although these findings require external validation in larger, longitudinal, biomarker-characterized cohorts.
A. Alagoz, Serap Ozturk, S. D. Bunul et al.· Diagnostics· 0 citations